Norina Gâvan

We are a German company specialized in treatment of diabetes and its complications, especially diabetic neuropathy. The modern treatment of diabetes employs a holistic approach that also includes the treatment of its concomitant diseases. Thus, the treatment area of diabetic polyneuropathies, the leading cause of diabetic foot syndrome and diabetes related amputations, has emerged as an area of interest over the last several years. Within the last 40 years, Wörwag Pharma has developed its international competence and reputation in the treatment area of diabetes and its sequelae – it has developed a specialized portfolio of micronutrients, called biofactors that covers both the pathogenetic and the symptomatic treatment of diabetic neuropathies. From now on, Wörwag Pharma wants to take the opportunity to support and to continue as a partner of all the activities concerning the diabetic neuropathies and diabetic foot, in the benefit of all the people involved in this pathology: patients, nurses, and doctors.